Guess which ASX healthcare stock just rocketed 46% on major news!

Investors are sending this ASX healthcare stock flying higher on Wednesday. But why?

| More on:
Lab worker puts hands in the air and dances around

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is down 0.14% in morning trade, but a little-known ASX healthcare stock is charging in the other direction.

Shares in the healthcare technology company closed yesterday at 5.5 cents and were trading at 8.0 cents apiece after market open today, putting the stock up a blistering 45.5%. After some likely profit-taking, shares are currently changing hands for 6.6 cents, up 20%.

Any guesses?

If you said Alcidion Group Ltd (ASX: ALC), give yourself a virtual gold star.

Created with Highcharts 11.4.3Alcidion Group PriceZoom1M3M6MYTD1Y5Y10YALL3 Jul 202324 Jul 2024Zoom ▾Sep '23Nov '23Jan '24Mar '24May '24Jul '24Sep '23Sep '23Jan '24Jan '24May '24May '24www.fool.com.au

Here's why investors are sending the ASX healthcare stock flying higher today.

What's boosting the ASX healthcare stock?

Alcidion is rocketing after the company announced that the North Cumbria Integrated Care NHS Foundation Trust (NCIC) has selected Alcidion as the preferred supplier by for its new Electronic Patient Record (EPR) system.

Located in the United Kingdom, North Cumbria provides hospital and community healthcare for approximately half a million people. The foundation operates across two acute care hospitals, eight community-based hospitals, eight Integrated Care Communities and several support staff locations.

The ASX healthcare stock will provide its Miya Precision platform, including Silverlink PCS, which is already live at NCIC. Alcidion said this will provide clinicians with real-time access to patient records while streamlining patient flow and improving clinical decision-making processes.

Subject to successful negotiation, Alcidion expects this to be a 10-year contract utilising the full Miya Precision product suite along with partner applications.

The total contract value (TCV) remains under negotiation, but Alcidion said it's likely to be between $30 million and $40 million over 10 years.

Alcidion is targeting deployment in the first quarter of calendar year 2025.

What did management say?

Commenting on the contract sending the ASX healthcare stock rocketing today, Alcidion managing director Kate Quirke said, "We are excited to build upon our existing relationship with NCIC by being selected as their preferred EPR supplier."

Quirke continued:

The Alcidion approach of providing an integrated, modular EPR offering allows NCIC to develop their existing digital footprint, protecting their existing investments and allowing them to realise the benefits of additional clinical capabilities such as electronic noting and integrated observations through integration with a number of existing systems.

At a time when the healthcare system is under enormous pressure, we see this increased speed to deliver value as a real opportunity for our customers.

Adrian Clements, executive medical director at NCIC, added:

Over the last few months, many of us have spent a great amount of time evaluating the various Electronic Patient Record systems in order to reach the correct conclusion to help us implement the best possible dynamic EPR system.

I feel assured and confident that selecting Alcidion will allow us to implement an EPR that enables high quality patient care, improves clinical safety and saves clinicians' valuable time.

With today's intraday gains factored in, the ASX healthcare stock is down 10% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Alcidion Group. The Motley Fool Australia has recommended Alcidion Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »